Search results for "docking"

showing 10 items of 299 documents

Getting Docking into Shape Using Negative Image-Based Rescoring

2019

The failure of default scoring functions to ensure virtual screening enrichment is a persistent problem for the molecular docking algorithms used in the structure-based drug discovery. To remedy this problem, elaborate rescoring and post-processing schemes have been developed with a varying degree of success, specificity, and cost. The negative imagebased rescoring (R-NiB) has been shown to improve the flexible docking performance markedly with a variety of drug targets.The yield improvement is achieved by comparing the alternative docking poses against the negative image of the target protein’s ligand-binding cavity. In other words, the shape and electrostatics of the binding pocket is dir…

Protein ConformationComputer scienceGeneral Chemical EngineeringDrug Evaluation PreclinicalBinding pocketLibrary and Information SciencesCrystallography X-RayMachine learningcomputer.software_genre01 natural sciencesArticledrugsAutodock vinaUser-Computer InterfaceDOCK0103 physical sciencesVirtual screening010304 chemical physicsbusiness.industryDrug discoveryGeneral Chemistrymolecular dockingPANTHER/ShaEP-based R-NiB methodologyAutoDock0104 chemical sciencesComputer Science ApplicationsMolecular Docking SimulationBenchmarking010404 medicinal & biomolecular chemistryDocking (molecular)Artificial intelligencebusinesscomputer
researchProduct

Conformation and concerted dynamics of the integrin-binding site and the C-terminal region of echistatin revealed by homonuclear NMR

2005

Copyright © by Portland Press. The final version of record is available at http://www.biochemj.org/bj/default.htm

Protein ConformationStereochemistryIntegrinNMR protein dynamics determinationTripeptideBiochemistryHomonuclear moleculeOff-resonance rotating-frame Overhauser enhancement spectroscopy (off-resonance ROESY)Protein structureSide chainAnimalsNuclear Magnetic Resonance BiomolecularMolecular BiologyIntegrin bindingRGD motifchemistry.chemical_classificationBinding Sites:CIENCIAS DE LA VIDA::Bioquímica [UNESCO]ChemistryEchistatin integrinSnakesUNESCO::CIENCIAS DE LA VIDA::BioquímicaCell BiologyRGD disintegrin; Echistatin; Integrin; NMR protein dynamics determination; Off-resonance rotating-frame Overhauser enhancement spectroscopy (off-resonance ROESY)Protein Structure TertiaryAmino acidRGD disintegrinDocking (molecular)EchistatinIntercellular Signaling Peptides and ProteinsPeptidesResearch ArticleProtein Binding
researchProduct

Inhibition in vivo of the activity of botulinum neurotoxin A by small molecules selected by virtual screening

2012

To search for small molecular size inhibitors of botulinum neurotoxin A (BoNT/A) endopeptidase activity, we have screened the NCI library containing about 1 million structures against the substrate binding pocket of BoNT/A. Virtual screening (VS) was performed with the software Glide (Grid-based ligand docking energetics) and the findings were confirmed by AutoDock. Ten compounds were found that had favorable energetic and glide criteria and 5 of these compounds were selected for their ability to protect mice in vivo against a lethal dose of BoNT/A. Each compound was incubated at different molar excesses with a lethal dose of the toxin and then the mixture injected intravenously into mice. …

Protein ConformationToxinChemistryNeurotoxinsLethal doseComputational BiologyAutoDockPharmacologyProtective AgentsToxicologymedicine.disease_causeSmall moleculeToxicologyMiceEndopeptidase activityDocking (molecular)In vivoToxicitymedicineAnimalsBotulinum Toxins Type ASequence AlignmentSoftwareToxicon
researchProduct

Targeting SARS-CoV-2 RBD Interface: a Supervised Computational Data-Driven Approach to Identify Potential Modulators

2020

Coronavirus disease 2019 (COVID-19) has spread out as a pandemic threat affecting over 2 million people. The infectious process initiates via binding of SARS-CoV-2 Spike (S) glycoprotein to host angiotensin-converting enzyme 2 (ACE2). The interaction is mediated by the receptor-binding domain (RBD) of S glycoprotein, promoting host receptor recognition and binding to ACE2 peptidase domain (PD), thus representing a promising target for therapeutic intervention. Herein, we present a computational study aimed at identifying small molecules potentially able to target RBD. Although targeting PPI remains a challenge in drug discovery, our investigation highlights that interaction between SARS-CoV…

Protein domainPneumonia ViralDruggabilityDrug Evaluation Preclinicalprotein-protein interactionsComputational biologyBiologyMolecular Dynamics SimulationPeptidyl-Dipeptidase AMolecular dynamics01 natural sciencesBiochemistryMolecular Docking SimulationAntiviral Agentsdockingmolecular dynamicProtein–protein interactionSmall Molecule LibrariesBetacoronavirusProtein DomainsDrug DiscoveryHumansGeneral Pharmacology Toxicology and PharmaceuticsPandemicsPharmacologyFull Paperpharmacophore010405 organic chemistryDrug discoverySARS-CoV-2Organic ChemistryCOVID-19Small molecule0104 chemical sciencesProtein-Protein InteractionMolecular Docking Simulation010404 medicinal & biomolecular chemistryDocking (molecular)Spike Glycoprotein CoronavirusdockingMolecular MedicineAngiotensin-Converting Enzyme 2PharmacophoreCoronavirus InfectionsProtein Binding
researchProduct

In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADME…

2020

The new coronavirus SARS-CoV-2 virus is causing a severe pneumonia in human, provoking the serious outbreak epidemic CoV-2. Since its appearance in Wuhan, China on December 2019, CoV-2 becomes the biggest challenge the world is facing today, including the discovery of antiviral drug for SARS-CoV-2. In this study, the potential inhibitory of a class of human SARS inhibitors, namely pyridine N-oxide derivatives, against CoV-2 was addressed by quantitative structure-activity relationship 3 D-QSAR. The reliable CoMSIA developed model of 110 pyridine N-oxide based-antiviral compounds, showed Q

Quantitative structure–activity relationship2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)PyridinesvirusesIn silicoSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030303 biophysicsQuantitative Structure-Activity Relationshipmedicine.disease_causeAntiviral Agents03 medical and health sciencesStructural BiologymedicineHumansProtease InhibitorsMolecular BiologyCoronavirus0303 health sciencesSARS-CoV-2ChemistryDrug discoveryCOVID-19virus diseasesGeneral Medicinerespiratory systembiochemical phenomena metabolism and nutritionVirologyrespiratory tract diseasesMolecular Docking SimulationJournal of Biomolecular Structure and Dynamics
researchProduct

New set of 2D/3D thermodynamic indices for proteins. A formalism based on "Molten Globule" theory

2010

Abstract We define eight new macromolecular indices, and several related descriptors for proteins. The coarse grained methodology used for its deduction ensures its fast execution and becomes a powerful potential tool to explore large databases of protein structures. The indices are intended for stability studies, predicting Φ -values, predicting folding rate constants, protein QSAR/QSPR as well as protein alignment studies. Also, these indices could be used as scoring function in protein-protein docking or 3D protein structure prediction algorithms and any others applications which need a numerical code for proteins and/or residues from 2D or 3D format.

Quantitative structure–activity relationshipComputer sciencePhysics and Astronomy(all)Protein structure predictionMolten globuleFolding degreeFormalism (philosophy of mathematics)Protein indicesProtein structureFPIDocking (molecular)Protein stabilityPhysical chemistryBiological systemStatistical potentialMacromoleculeProtein folding descriptor
researchProduct

Molecular modelling and QSAR in the discovery of HIV-1 integrase inhibitors

2007

The treatment regimens for the HIV-1 have mainly included reverse transcriptase or protease inhibitors but their long-term clinical utility is limited by severe side effects and viral drug resistance. A new attractive target for chemotherapeutic intervention can be the Integrase enzyme, that mediates the integration of HIV-1 DNA into a host chromosome, for which there is no known counterparts in the host cell. A number of derivatives have been found to inhibit IN in in vitro assays, but no successful drug based on them has emerged so far, although many compounds have been proposed. Moreover most of the inhibitors do not belong to a very precise structural class: this fact makes these compou…

Quantitative structure–activity relationshipProteasebiologymedicine.medical_treatmentIntegrase inhibitorDrug designGeneral MedicineComputational biologyDe novo design Docking HIV-1 integrase inhibitors Molecular dynamics Molecular modelling Pharmacophore QSARBioinformaticsIntegraseDocking (molecular)Host chromosomeDrug Discoverybiology.proteinmedicineMolecular MedicinePharmacophore
researchProduct

Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors

2019

[EN] The development and advancement of prostate cancer (PCa) into stage 4, where it metastasize, is a major problem mostly in elder males. The growth of PCa cells is stirred up by androgens and androgen receptor (AR). Therefore, therapeutic strategies such as blocking androgens synthesis and inhibiting AR binding have been explored in recent years. However, recently approved drugs (or in clinical phase) failed in improving the expected survival rates for this metastatic-castration resistant prostate cancer (mCRPC) patients. The selective CYP17A1 inhibition of 17,20-lyase route has emerged as a novel strategy. Such inhibition blocks the production of androgens everywhere they are found in t…

Quantitative structure–activity relationshipStereochemistry01 natural sciencesBiochemistryStructure-Activity Relationship3D-QSAR pharmacophore modelDrug DiscoveryCytochrome P-450 Enzyme InhibitorsHumansStructure–activity relationshipCYP17A1 InhibitorMolecular BiologyDensity Functional TheoryVirtual screeningDose-Response Relationship DrugMolecular Structure010405 organic chemistryChemistryOrganic ChemistryProspective computational designSteroid 17-alpha-Hydroxylasecomputer.file_format1720-lyase selective inhibitionProtein Data BankLyase0104 chemical sciencesMolecular Docking Simulation010404 medicinal & biomolecular chemistryDocking (molecular)CYP17A1 inhibitorsMetastatic-castration resistant prostate cancerPharmacophorecomputer
researchProduct

Harmonization of QSAR Best Practices and Molecular Docking Provides an Efficient Virtual Screening Tool for Discovering New G-Quadruplex Ligands

2015

Telomeres and telomerase are key players in tumorogenesis. Among the various strategies proposed for telomerase inhibition or telomere uncapping, the stabilization of telomeric G-quadruplex (G4) structures is a very promising one. Additionally, G4 stabilizing ligands also act over tumors mediated by the alternative elongation of telomeres. Accordingly, the discovery of novel compounds able to act on telomeres and/or inhibit the telomerase enzyme by stabilizing DNA telomeric G4 structures as well as the development of approaches efficiently prioritizing such compounds constitute active areas of research in computational medicinal chemistry and anticancer drug discovery. In this direction, we…

Quantitative structure–activity relationshipTelomeraseGeneral Chemical EngineeringDrug Evaluation PreclinicalQuantitative Structure-Activity RelationshipComputational biologyLibrary and Information SciencesBiologyG-quadruplexCrystallography X-RayLigandsMolecular Docking Simulationchemistry.chemical_compoundDrug DiscoveryHumansCell ProliferationGeneticsVirtual screeningMolecular StructureDrug discoveryQSARGeneral ChemistryFibroblastsTelomereComputer Science ApplicationsTelomereG-QuadruplexesMolecular Docking SimulationchemistryAcridinesDNAHeLa Cells
researchProduct

Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes

2015

The adverse effects to humans and environment of only few chemicals are well known. Absorption, distribution, metabolism, and excretion (ADME) are the steps of pharmaco/toxicokinetics that determine the internal dose of chemicals to which the organism is exposed. Of all the xenobiotic-metabolizing enzymes, the cytochrome P450 (CYP) enzymes are the most important due to their abundance and versatility. Reactions catalyzed by CYPs usually turn xenobiotics to harmless and excretable metabolites, but sometimes an innocuous xenobiotic is transformed into a toxic metabolite. Data on ADME and toxicity properties of compounds are increasingly generated using in vitro and modeling (in silico) tools.…

Quantitative structure–activity relationshipcytochrome P450In silicoMetabolitexenobioticReviewBiologyPharmacologyXenobiotics03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCYP P450sToxicokineticsPharmacology (medical)aineenvaihdunta030304 developmental biologyADMEPharmacology0303 health sciencesIn silico modelingQSARlcsh:RM1-950Cytochrome P450docking studiesmodelingLigand (biochemistry)3. Good healthbiotransformationslcsh:Therapeutics. PharmacologychemistryBiochemistryin silico030220 oncology & carcinogenesisbiology.proteinXenobioticmetabolismFrontiers in Pharmacology
researchProduct